HOME Top Market Reports Bioburden Testing Market by Product [Instrument (PCR, Microscopes), & Consumables (Kit, Reagent)], Test (Aerobic, Anaerobic, Fungi, Spore), Application (Raw Material, In-process) & End User (Pharmaceutical, Biotechnology, CMO) - Forecast to 2019

Bioburden Testing Market by Product [Instrument (PCR, Microscopes), & Consumables (Kit, Reagent)], Test (Aerobic, Anaerobic, Fungi, Spore), Application (Raw Material, In-process) & End User (Pharmaceutical, Biotechnology, CMO) - Forecast to 2019

By: marketsandmarkets.com
Publishing Date: May 2015
Report Code: BT 3394

Discount on Reports  

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The bioburden testing market is expected to reach $565.6 Million by 2019 from $354.4 Million in 2014, at a CAGR of 9.8% from 2014 to 2019. Major factors driving the growth of this market include the growing medical device industry, changing trends in the pharmaceutical and biotechnology industries, increasing food safety concerns to boost this market, strong trend of R&D investments in life sciences, and increasing product recalls due to microbial contamination. However, high cost of instruments and complex and time-consuming regulatory standards which lengthen the approval process in some countries may hinder the growth of this market. Emerging economies such as India and China present an array of opportunities for this market.

North America dominated the microbial limit testing market, with the U.S. accounting for a major market share in 2014. However, Asia is poised to grow at the highest CAGR during the forecast period. Growth in the Asian market will be driven by factors such as strong investments and rapid growth in the pharmaceutical and biotechnology industries, growing medical device industry, government initiatives and rising awareness for bioburden testing in various Asian countries.

Prominent players in the bioburden testing market are Charles River Laboratories International, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), SGS S.A. (Switzerland), WuXi PharmaTech (Cayman) Inc. (China), Merck & Co., Inc. (U.S.), Becton, Dickinson and Company (U.S.), North American Science Associates, Inc. (NAMSA) (U.S.), Nelson Laboratories (U.S.), Pacific Biolabs (U.S.), and ATS Labs, Inc. (U.S.).

Scope of the Report

This research report covers the bioburden testing market by product, test type, applications, end user, and region.

Bioburden Testing Market, by Product

  • Consumables
    • Culture Media and Reagents Kits
    • Other Consumables
  • Instruments
    • Automated Microbial Identification Systems
    • Polymerase Chain Reaction (PCR)
    • Microscopes
    • Other Instruments

Bioburden Testing Market, by Test Type

  • Aerobic Count
  • Anaerobic Count
  • Fungi/Mold Count
  • Spores Count

Bioburden Testing Market, by Application

  • Raw Material Testing
  • Medical Devices Testing
  • In-process Testing
  • Sterilization Validation Testing
  • Equipment Cleaning Validation

Bioburden Testing Market, by End User

  • Pharmaceutical and Biotechnology Companies
  • Medical Device Manufacturers
  • Contract Manufacturing Organizations (CMOs)
  • Manufacturers of Food & Beverage and Agricultural Products
  • Microbial Testing Laboratories

Bioburden Testing Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
  • Asia
  • Rest of the World (RoW)

Table of Contents

1 Introduction
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Market Stakeholders

2 Research Methodology
    2.1 Market Size Estimation
    2.2 Market Breakdown & Data Triangulation
    2.3 Key Data From Secondary Sources
    2.4 Key Data From Primary Sources
    2.5 Key Industry Insights
    2.6 Assumptions for the Study

3 Executive Summary

4 Premium Insights
    4.1 Bioburden Testing Market, By Product
    4.2 Bioburden Testing Market, for Instruments
    4.3 Bioburden Testing Market, By Test Types
    4.4 Bioburden Testing Market, By Applications
    4.5 Geographic Snapshot
    4.6 Bioburden Testing Market, By End Users

5 Market Overview
    5.1 Introduction
    5.2 Market Segmentation
           5.2.1 Bioburden Testing Market By Product
           5.2.2 Bioburden Testing Market By Test Type
           5.2.3 Bioburden Testing Market By Application
           5.2.4 Bioburden Testing Market By End User
           5.2.5 Bioburden Testing Market By Region
    5.3 Market Dynamics
           5.3.1 Drivers
                    5.3.1.1 Growing Medical Device, Pharmaceutical and Biotechnology Industries
                    5.3.1.2 Increasing Food & Beverage Safety Concerns
                    5.3.1.3 Increasing Product Recall Due to Microbial Contamination
                    5.3.1.4 Strong Trend of R&D Investments in Life Sciences
                    5.3.1.5 Growing Healthcare Industry and Medical Spending
           5.3.2 Restrain
                    5.3.2.1 High Costs of Microbial Enumeration Instruments
           5.3.3 Opportunities
                    5.3.3.1 Opportunity in Contract Manufacturing Market
                    5.3.3.2 Emerging Economies
           5.3.4 Challenges
                    5.3.4.1 Shortage of Knowledgeable and Skilled Professionals
                    5.3.4.2 Stringent Regulatory Policies for Instruments and Consumables

6 Industry Insights
    6.1 Porter’s Five Forces Analysis
           6.1.1 Threat From New Entrants
           6.1.2 Threat From Substitutes
           6.1.3 Bargaining Power of Suppliers
           6.1.4 Bargaining Power of Buyers
           6.1.5 Intensity of Competitive Rivalry
    6.2 Strategic Benchmarking

7 Bioburden Testing Market, By Product
    7.1 Introduction
    7.2 Consumables
           7.2.1 Culture Media, Reagents & Kits
           7.2.2 Other Consumables
    7.3 Instruments
           7.3.1 PCR
           7.3.2 Microscopes
           7.3.3 Automated Microbial Identification Systems
           7.3.4 Other Instruments

8 Bioburden Testing Market, By Test Type
    8.1 Introduction
    8.2 Aerobic Count
    8.3 Anaerobic Count
    8.4 Fungi / Mold Count
    8.5 Spore Count

9 Bioburden Testing Market, By Application
    9.1 Introduction
    9.2 Raw Materials Testing
    9.3 Medical Devices Testing
    9.4 In-Process Material Testing
    9.5 Sterilization Validation Testing
    9.6 Equipment Cleaning Validation

10 Bioburden Testing Market, By End User
     10.1 Introduction
     10.2 Pharmaceutical & Biotechnology Companies
     10.3 Medical Device Manufacturers
     10.4 Contract Manufacturing Organizations (CMOS)
     10.5 Manufacturers of Food & Eberage and Agriculture Products
     10.6 Microbial Testing Laboratories

11 Geographic Analysis
     11.1 Introduction
     11.2 North America
             11.2.1 U.S.
             11.2.2 Canada
     11.3 Europe
     11.4 Asia
     11.5 Rest of the World (RoW)

12 Competitive Landscape
     12.1 Overview
     12.2 Competitive Situation and Trends
             12.2.1 Acquisitions
             12.2.2 New Product and Service Launches
             12.2.3 Expansion
             12.2.4 Others

13 Company Profiles
     13.1 Introduction
     13.2 Charles River Laboratories International, Inc.
             13.2.1 Business Overview
             13.2.2 Products & Services
             13.2.3 Recent Developments
             13.2.4 MnM View
     13.3 Sigma-Aldrich Corporation
             13.3.1 Business Overview
             13.3.2 Products & Services
             13.3.3 Recent Developments
             13.3.4 MnM View
     13.4 SGS S.A.
             13.4.1 Business Overview
             13.4.2 Services
             13.4.3 Recent Developments
             13.4.4 MnM View
     13.5 WUXI Pharmatech (Cayman), Inc.
             13.5.1 Business Overview
             13.5.2 Services
             13.5.3 Recent Developments
             13.5.4 MnM View
     13.6 Merck & Co., Inc.
             13.6.1 Business Overview
             13.6.2 Products & Services
             13.6.3 Recent Developments
             13.6.4 MnM View
     13.7 Becton, Dickinson, and Company
             13.7.1 Business Overview
             13.7.2 Product & Services
             13.7.3 Key Strategy
             13.7.4 Recent Developments
     13.8 North American Science Associates, Inc. (NAMSA)
             13.8.1 Business Overview
             13.8.2 Services
             13.8.3 Key Strategy
             13.8.4 Recent Developments
     13.9 Nelson Laboratories, Inc.
             13.9.1 Business Overview
             13.9.2 Services
             13.9.3 Key Strategy
             13.9.4 Recent Developments
     13.10 Pacific Biolabs
             13.10.1 Business Overview
             13.10.2 Service Portfolio
             13.10.3 Key Strategy
             13.10.4 Recent Developments
     13.11 ATS Labs, Inc.
             13.11.1 Business Overview
             13.11.2 Services
             13.11.3 Key Strategy
             13.11.4 Recent Developments

14 Appendix


List of Tables (96 Tables)

Table 1 Growing Medical Device, Pharmaceutical and Biotechnology Industries Propelling the Growth of the Bioburden Testing Market
Table 2 High Costs of Microbial Enumeration Instruments to Hinder Market Growth
Table 3 Contract Manufacturing to Create New Growth Opportunities for Market
Table 4 Shortage of Knowledgeable and Skilled Professionals A Major Challenge for the Market
Table 5 Microbial Limit Testing Market Size, By Product 2012–2019 ($Million)
Table 6 Market Size for Consumables, By Type, 2012-2019 ($Million)
Table 7 Microbial Limit Testing Market Size for Consumables, By Region, 2012-2019 ($Million)
Table 8 North America: Market Size for Consumables, By Country, 2012-2019 ($Million)
Table 9 Market Size for Culture Media, Reagents & Kits, By Region, 2012-2019 ($Million)
Table 10 North America: Market Size for Culture Media, Reagents & Kits, By Region, 2012-2019 ($Million)
Table 11 Market Size for Other Consumables, By Region, 2012-2019 ($Million)
Table 12 North America:  Market Size for Other Consumables, By Country, 2012-2019 ($Million)
Table 13 Bioburden Testing Market Size for Instruments, By Type, 2012-2019 ($Million)
Table 14  Market Size for Instruments, By Region, 2012-2019 ($Million)
Table 15 North America: Market Size for Instruments, By Country, 2012-2019 ($Million)
Table 16  Microbial Limit Testing Market Size for PCR, By Region, 2012-2019 ($Million)
Table 17 North America: Bioburden Testing Market Size for PCR, By Country, 2012-2019 ($Million)
Table 18  Market Size for Microscopes, By Region, 2012-2019 ($Million)
Table 19 North America: Bioburden Testing Market Size for Microscopes, By Country, 2012-2019 ($Million)
Table 20 Market Size for Automated Microbial Identification System, By Region, 2012-2019 ($Million)
Table 21 North America: Bioburden Testing Market Size for Automated Microbial Identification System, By Country, 2012-2019 ($Million)
Table 22 Market Size for Other Instruments, By Region, 2012-2019 ($Million)
Table 23 North America: Bioburden Testing Market Size for Other Instruments, By Country, 2012-2019 ($Million)
Table 24  Market Size, By Test 2012–2019 ($Million)
Table 25 Microbial Limit Testing Market Size for Aerobic Count, By Region, 2012-2019 ($Million)
Table 26 North America:  Market Size for Aerobic Count, By Country, 2012-2019 ($Million)
Table 27 Bioburden Testing Market Size for Anaerobic Count, By Region, 2012–2019 ($Million)
Table 28 North America: Bioburden Testing Market Size for Anaerobic Count, By Country, 2012–2019 ($Million)
Table 29 Market Size for Fungi/Mold Count, By Region, 2012–2019 ($Million)
Table 30 North America: Microbial Limit Testing Market Size for Fungi/Mold Count, By Country, 2012–2019 ($Million)
Table 31 Market Size for Spore Count, By Region, 2012–2019 ($Million)
Table 32 North America: Bioburden Testing Market Size for Spore Count, By Country, 2012–2019 ($Million)
Table 33 Microbial Limit Testing Market Size, By Application 2012–2019 ($Million)
Table 34 Market Size for Raw Materials Testing, By Region, 2012-2019 ($Million)
Table 35 North America:  Market Size for Raw Materials Testing, By Country, 2012-2019 ($Million)
Table 36 Market Size for Medical Devices Testing, By Region, 2012-2019 ($Million)
Table 37 North America: Bioburden Testing Market Size for Medical Devices Testing, By Country, 2012-2019 ($Million)
Table 38 Microbial Limit Testing Market Size for In-Process Testing, By Region, 2012-2019 ($Million)
Table 39 North America: Bioburden Testing Market Size for In-Process Testing, By Country, 2012-2019 ($Million)
Table 40 Microbial Limit Testing Market Size for Sterilization Validation Testing, By Region, 2012-2019 ($Million)
Table 41 North America: Market Size for Sterilization Validation Testing, By Country, 2012-2019 ($Million)
Table 42 Bioburden Testing Market Size for Equipment Cleaning Validation, By Region, 2012-2019 ($Million)
Table 43 North America: Market Size for Equipment Cleaning Validation , By Country, 2012-2019 ($Million)
Table 44 Bioburden Testing Market Size, By End User 2012–2019 ($Million)
Table 45 Microbial Limit Testing Market Size for Pharmaceutical Companies & Biotechnology Companies, By Region, 2012-2019 ($Million)
Table 46 North America: Bioburden Testing Market Size for Pharmaceutical Companies & Biotechnology Companies, By Country, 2012-2019 ($Million)
Table 47 Market Size for Medical Device Manufacturers, By Region, 2012-2019 ($Million)
Table 48 North America: Bioburden Testing Market Size for Medical Device Manufacturers, By Country, 2012-2019 ($Million)
Table 49 Market Size for CMOS, By Region, 2012-2019 ($Million)
Table 50 North America: Bioburden Testing Market Size for CMOS, By Country, 2012-2019 ($Million)
Table 51 Market Size for Manufacturers of Food & beverage and Agriculture Products, By Region, 2012-2019 ($Million)
Table 52 North America: Microbial Limit Testing Market Size for Manufacturers of Food & beverage and Agriculture Products, By Country, 2012-2019 ($Million)
Table 53 Market Size for Microbial Testing Labs, By Region, 2012-2019 ($Million)
Table 54 North America: Bioburden Testing Market Size for Microbial Testing Labs, By Country, 2012-2019 ($Million)
Table 55 Market Size, By Region 2012–2019 ($Million)
Table 56 North America: Microbial Limit Testing Market Size, By Country 2012–2019 ($Million)
Table 57 North America: Market Size, By Product 2012–2019 ($Million)
Table 58 North America: Bioburden Testing Consumables Market Size, By Type 2012–2019 ($Million)
Table 59 North America: Bioburden Testing Instruments Market Size, By Type 2012–2019 ($Million)
Table 60 North America: Market Size, By Test 2012–2019 ($Million)
Table 61 North America: Market Size, By Application 2012–2019 ($Million)
Table 62 North America: Microbial Limit Testing Market Size, By End User 2012–2019 ($Million)
Table 63 U.S.: Market Size, By Product 2012–2019 ($Million)
Table 64 U.S.: Bioburden Testing Consumables Market Size, By Type 2012–2019 ($Million)
Table 65 U.S.: Bioburden Testing Instruments Market Size, By Type 2012–2019 ($Million)
Table 66 U.S.: Market Size, By Test 2012–2019 ($Million)
Table 67 U.S.: Market Size, By Application 2012–2019 ($Million)
Table 68 U.S.: Microbial Limit Testing Market Size, By End User 2012–2019 ($Million)
Table 69 Canada: Market Size, By Product 2012–2019 ($Million)
Table 70 Canada: Bioburden Testing Consumables Market Size, By Type 2012–2019 ($Million)
Table 71 Canada: Bioburden Testing Instruments Market Size, By Type 2012–2019 ($Million)
Table 72 Canada: Market Size, By Test 2012–2019 ($Million)
Table 73 Canada: Microbial Limit Testing Market Size, By Application 2012–2019 ($Million)
Table 74 Canada: Microbial Limit Testing Market Size, By End User 2012–2019 ($Million)
Table 75 Europe: Market Size, By Product 2012–2019 ($Million)
Table 76 Europe: Bioburden Testing Consumables Market Size, By Type 2012–2019 ($Million)
Table 77 Europe: Bioburden Testing Instruments Market Size, By Type 2012–2019 ($Million)
Table 78 Europe: Microbial Limit Testing Market Size, By Test 2012–2019 ($Million)
Table 79 Europe: Microbial Limit Testing Market Size, By Application 2012–2019 ($Million)
Table 80 Europe: Market Size, By End User 2012–2019 ($Million)
Table 81 Asia: Market Size, By Product 2012–2019 ($Million)
Table 82 Asia: Bioburden Testing Consumables Market Size, By Type 2012–2019 ($Million)
Table 83 Asia: Bioburden Testing Instruments Market Size, By Type 2012–2019 ($Million)
Table 84 Asia: Market Size, By Test 2012–2019 ($Million)
Table 85 Asia: Market Size, By Application 2012–2019 ($Million)
Table 86 Asia: Market Size, By End User 2012–2019 ($Million)
Table 87 RoW: Market Size, By Product 2012–2019 ($Million)
Table 88 RoW: Bioburden Testing Consumables Market Size, By Type 2012–2019 ($Million)
Table 89 RoW: Bioburden Testing Instruments Market Size, By Type 2012–2019 ($Million)
Table 90 RoW: Market Size, By Test 2012–2019 ($Million)
Table 91 RoW: Microbial Limit Testing Market Size, By Application 2012–2019 ($Million)
Table 92 RoW: Microbial Limit Testing Market Size, By End User 2012–2019 ($Million)
Table 93 Recent Acquisitions
Table 94 Recent Product and Service Launches
Table 95 Recent Expansion
Table 96 Recent Other Strategies
 
List of Figures (46 Figures)
 
Figure 1 Research Methodology
Figure 2 Top-Down Approach
Figure 3 Bottom-Up Approach
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Bioburden Testing Market Snapshot, By Product (2014 vs. 2019): Consumables Segment to Dominate the Market During the Forecast Period
Figure 6 Market Snapshot, By Test (2014 vs. 2019): Aerobic Count Segment to Witness Highest Growth
Figure 7 Market Snapshot, By Application (2014 vs. 2019): Raw Material Testing Segment is Dominant in the Market
Figure 8 Pharmeceutical and Biotechnology Companies Held the Largest Share of the Bioburden Testing Market in 2014
Figure 9 Global Market, By Region, 2014: North America Accounted for the Largest Share While Asia is Expected to Grow at A Highest CAGR From 2014-2019
Figure 10 Consumables Offers Attractive Market Opportunities
Figure 11 PCR Segment to Grow at Highest CAGR
Figure 12 Culture Media, Reagents and Kits Segment to Grow at Highest CAGR
Figure 13 Aerobic Count to Grow at Highest CAGR
Figure 14 Raw Material Testing to Account for the Largest Share of the Market
Figure 15 Asia to Dominate Bioburden Testing Market
Figure 16 Pharmaceutical Companies & Biotechnology Companies Offer Highest Growth Opportunities
Figure 17 Bioburden Testing Market Segmentation By Product
Figure 18 Market Segmentation By Test Type
Figure 19 Market Segmentation By Application
Figure 20 Market Segmentation By End User
Figure 21 Market Segmentation By Region
Figure 22 Growing Medical Device, Pharmaceutical and Biotechnology Industries to Fuel Market Growth
Figure 23 Porter’s Five Forces Analysis
Figure 24 Strategic Benchmarking: Top Players Adopted Acquisitions as Key Growth Strategies
Figure 25 Consumables Market to Witness Significant Growth in the Forecast Period
Figure 26 Asia to Record the Highest Growth Rate in the Consumables Market
Figure 27 Asia Will Grow at Highest CAGR in the Forecast Period 2015-2019
Figure 28 Raw Materials Testing Segment to Witness Growth in the Forecast Period
Figure 29 CMOS are Expected Grow at the Highest CAGR
Figure 30 Asian Market for Bioburden Testing is Expected to Grow at Highest Rate From 2014 to 2019
Figure 31 Asia: High Demand for Veterinary Software From End Users
Figure 32 North America: Market Snapshot
Figure 33 Major Players Adopted Acquisitions and New Product and Service Launches as A Key Growth Strategy Between 2012 and 2014
Figure 34 Market Evolution Framework: Acquisitions and Product and Service Launches Fuelled Market Growth
Figure 35 Acquisitions, New Product and Service Launches Were Preferred Strategies for Market Players
Figure 36 Geographic Revenue Mix of Top 4 Market Players
Figure 37 Charles River Laboratories International, Inc.: Company Snapshot
Figure 38 Sigma-Aldrich Corporation: Company Snapshot
Figure 39 SGS SA: Company Snapshot
Figure 40 WUXI Pharmatech (Cayman) Inc.: Company Snapshot
Figure 41 Merck & Co., Inc.: Company Snapshot
Figure 42 Becton, Dickinson and Company: Company Snapshot
Figure 43 North American Science Associates, Inc.: Company Snapshot
Figure 44 Nelson Laboratories Inc.: Company Snapshot
Figure 45 Pacific Biolabs: Company Snapshot
Figure 46 ATS Labs, Inc.: Company Snapshot

Bioburden testing is performed on pharmaceutical products, biotechnological products, and medical devices for quality purposes. The main aim of bioburden testing is to measure the number of viable microorganisms on the product with the help of consumables and instruments. Bioburden testing is a growing market, driven by the growing medical device industry, changing trends in the pharmaceutical and biotechnology industries, increasing food safety concerns to boost the microbial identification market, strong trend of R&D investments in life sciences, increasing product recalls due to microbial contamination, and growing awareness of bioburden testing in developing nations. However, factors such as high cost of instruments and complex and time-consuming regulatory standards to lengthen the approval process in some countries may hinder the growth of this market.

The bioburden testing market is expected to reach $565.6 Million by 2019 from $354.4 Million in 2014, growing at a CAGR of 9.8% from 2014 to 2019. This market is segmented on the basis of products, test types, applications, end users, and regions.

On the basis of products, the microbial limit testing market is segmented into consumables and instruments. The consumables market is further segmented into culture media and reagents & kits and other consumables. The instruments market is further segmented into PCR, microscopes, automated microbial identification systems, and other instruments. On the basis of test types, the global bioburden market is segmented into aerobic count, anaerobic count, fungi/mold count, and spores count. On the basis of applications, the market is segmented into raw material testing, medical devices testing, in-process testing, sterilization validation testing, and equipment cleaning validation. Based on end users, the market is segmented into pharmaceutical and biotechnology companies, medical devices manufacturers, contract manufacturing organizations (CMOs), manufacturers of food & beverage and agricultural products, and microbial testing laboratories.

Bioburden Testing Market, by Region, 2014

Bioburden Testing Market

Sources: Annual Reports, SEC Filings, Press Releases, Investor Presentations, World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), Association of Pharmaceutical Research and Development, Biotechnology and Biological Science Research Council, Association for the Advancement of Medical Instrumentation (AAMI), The American Institute of Biological Sciences, Industry Canada, The Association of the British Pharmaceutical Industry, U.S. Food and Drug Administration (FDA), Medical Technology Association of Australia, China Association for Medical Device Industry (CAMDI), Indian Drug Manufacturers’ Association (IDMA), The China Pharmaceutical Industry Association (CPIA), Association of Indian Medical Device Industry (AIMED), Japan Pharmaceutical Manufacturers Association (JPMA), Brazilian Association of Medical Devices Manufacturers (ABIMO), Journals, Expert Interviews, and MarketsandMarkets Analysis

The global microbial limit testing market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America will continue to dominate the market in the forecast period. Over the next five years, the growth of the market in the Asian region is likely to be centered on China and India.

Key players in the bioburden testing market include Charles River Laboratories International, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), SGS S.A. (Switzerland), WuXi PharmaTech (Cayman) Inc. (China), Merck & Co., Inc. (U.S.), Becton, Dickinson and Company (U.S.), North American Science Associates, Inc. (NAMSA) (U.S.), Nelson Laboratories (U.S.), Pacific Biolabs (U.S.), and ATS Labs, Inc. (U.S.).

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Biotechnology Markets on KnowledgeStore
Request Demo